Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Boston Scientific Scores a Victory in Stent War with Cordis - Medical Product Outsourcing

Boston Scientific Scores a Victory in Stent War with Cordis

Boston Scientific granted summary judgment of infringement in case against Cordis.

The ongoing battle between Boston Scientific Corp. and Johnson & Johnson’s Cordis Corp. intensified this week when Boston Scientific won a motion for summary judgment of infringement, while Cordis was denied a request to delay jury trial.

The case concerns 2.25-millimeter stents; Boston Scientific and Cordis are the only U.S. manufacturers of these models.

Both companies alleged patent infringement in 2003. The jury ruled in favor of Boston Scientific on the grounds that Cordis’ Cypher and BX Velocity stents were in violation of the patent; the ruling was upheld on appeal.

The case will resume May 5, with U.S. District Court for Delaware Judge Susan Robinson presiding over the case.

It is one of few wins for Boston Scientific in recent years. The company paid $716 million to Cordis in 2009 to settle 14 patent infringement suits for stent technologies. Not included in that group was a lawsuit regarding a drug-eluting stent. In February, Boston Scientific was denied a request to suspend the lawsuit pending review by the U.S. Patent and Trademark Office because it would give an unfair disadvantage to Cordis.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters